» Articles » PMID: 3367095

A 52-kD Protein is a Novel Component of the SS-A/Ro Antigenic Particle

Overview
Journal J Exp Med
Date 1988 May 1
PMID 3367095
Citations 129
Authors
Affiliations
Soon will be listed here.
Abstract

Anti-SS-A/Ro autoantibodies are found in the sera of patients with Sjogren's syndrome (SS) and SLE. In the course of analyzing 61 SS patients for their autoantibody profiles, we found that 42 were positive for anti-SS-A by double diffusion in agarose and demonstrated precipitin lines identical to that produced by a prototype anti-SS-A serum. Further analysis of these SS-A antibody-positive sera by Western blotting of cell extracts revealed that 21 sera reacted with two proteins of 60 and 52 kD, 13 sera reacted with 52-kD protein, two detected only 60 kD, while six were nonreactive. Affinity-purified anti-60-kD and anti-52-kD antibodies reacted exclusively with their corresponding antigens. Partial proteolysis of these proteins did not reveal common degradation fragments. Thus the 52- and 60-kD proteins were found to be antigenically and apparently structurally distinct from each other. They were also distinct from 48-kD SS-B/La protein. In immunoprecipitation using labeled cell extracts, affinity-purified anti-52-kD antibodies brought down the 52-kD protein as well as the 60-kD band. In [32P]orthophosphate-labeled HeLa cell extract both antibodies precipitated the same spectrum of small RNAs (hYl-5). In indirect immunofluorescence, anti-52-kD and anti-60-kD antibodies immunolocalized in similar subcellular structures and showed similar punctate nuclear staining patterns. Western blot analysis revealed that both proteins were present in lymphocytic as well as epithelial human cell lines tested. The data above define a new antigen of 52 kD which is another component of the SS-A particle and is associated in complex formation with the previously reported 60-kD protein.

Citing Articles

Targeting the TRIM21-PD-1 axis potentiates immune checkpoint blockade and CAR-T cell therapy.

Shi J, Zhang Z, Chen H, Yao Y, Ke S, Yu K Mol Ther. 2025; 33(3):1073-1090.

PMID: 39905727 PMC: 11897759. DOI: 10.1016/j.ymthe.2025.01.047.


Long-term outcome of interstitial lung disease in patients with primary Sjögren's syndrome: a retrospective observational study.

Koh J, Park Y, Lee J, Jeon H, Moon S, Kim Y Korean J Intern Med. 2024; 40(1):148-159.

PMID: 39449593 PMC: 11725482. DOI: 10.3904/kjim.2023.402.


Autoantibodies in systemic sclerosis overlap syndrome and their correlation with organ damage and survival.

Wang F, Li C, Li X, Li S, Jia Y Ann Med. 2024; 56(1):2407526.

PMID: 39348269 PMC: 11443570. DOI: 10.1080/07853890.2024.2407526.


Equol exerts anti-tumor effects on choriocarcinoma cells by promoting TRIM21-mediated ubiquitination of ANXA2.

Liu X, Wang Z, Wei Q, Song Y, Ma X Biol Direct. 2024; 19(1):78.

PMID: 39242533 PMC: 11378480. DOI: 10.1186/s13062-024-00519-5.


Roles of TRIM21/Ro52 in connective tissue disease-associated interstitial lung diseases.

Gong X, He S, Cai P Front Immunol. 2024; 15:1435525.

PMID: 39165359 PMC: 11333224. DOI: 10.3389/fimmu.2024.1435525.


References
1.
Guldner H, Lakomek H, BAUTZ F . Identification of human Sm and (U1) RNP antigens by immunoblotting. J Immunol Methods. 1983; 64(1-2):45-59. DOI: 10.1016/0022-1759(83)90383-6. View

2.
Wolin S, Steitz J . Genes for two small cytoplasmic Ro RNAs are adjacent and appear to be single-copy in the human genome. Cell. 1983; 32(3):735-44. DOI: 10.1016/0092-8674(83)90059-4. View

3.
Harmon C, Deng J, Peebles C, Tan E . The importance of tissue substrate in the SS-A/Ro antigen-antibody system. Arthritis Rheum. 1984; 27(2):166-73. DOI: 10.1002/art.1780270207. View

4.
Elkon K, Culhane L . Partial immunochemical characterization of the Ro and La proteins using antibodies from patients with the sicca syndrome and lupus erythematosus. J Immunol. 1984; 132(5):2350-6. View

5.
Wolin S, Steitz J . The Ro small cytoplasmic ribonucleoproteins: identification of the antigenic protein and its binding site on the Ro RNAs. Proc Natl Acad Sci U S A. 1984; 81(7):1996-2000. PMC: 345423. DOI: 10.1073/pnas.81.7.1996. View